An Analysis of Demographics and Inhaled Corticosteroid Use on COVID-19 Outcomes Among Hospitalized Adult Asthmatics: An Early Experience at a NY Hospital System

PURPOSE: It is unclear whether asthma is a risk factor for the development of COVID-19; however, severe asthma is a risk factor for morbidity and mortality. While systemic corticosteroids are beneficial during the inflammatory phase of COVID-19, the impact of inhaled corticosteroids (ICS) is unclear...

Descripción completa

Detalles Bibliográficos
Autores principales: Farzan, Sherry, Rebaza, André, Rai, Shipra, Santiago, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672491/
https://www.ncbi.nlm.nih.gov/pubmed/34924762
http://dx.doi.org/10.2147/JAA.S337518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672491/
https://www.ncbi.nlm.nih.gov/pubmed/34924762
http://dx.doi.org/10.2147/JAA.S337518

Ejemplares similares